New foot scanner aims to help diabetics spot problems early

NCT ID NCT07666087

Not yet recruiting Knowledge-focused Sponsor: Diabetis JSC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study will test how easy it is for 20 adults with diabetes to set up and use the Feetsee foot monitoring device at home over 8 weeks. Participants will use the device and app on their own, following the instructions provided. The goal is to see if people can use it correctly without extra help, which could lead to better foot care and fewer complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Feetsee foot monitoring device
What this could lead to: If successful, this could show that the Feetsee device is easy for people with diabetes to use at home, potentially helping them monitor foot health and prevent complications.
What could go wrong: This is a very small, early-stage usability study with only 20 participants. It does not test whether the device improves health outcomes, so it may not lead to any direct medical benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES

Contacts and locations

Locations

UT Health San Antonio

San Antonio, Texas, 78229, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.